{
     "PMID": "20624596",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20100806",
     "LR": "20170922",
     "IS": "1097-4199 (Electronic) 0896-6273 (Linking)",
     "VI": "67",
     "IP": "1",
     "DP": "2010 Jul 15",
     "TI": "The extracellular matrix molecule hyaluronic acid regulates hippocampal synaptic plasticity by modulating postsynaptic L-type Ca(2+) channels.",
     "PG": "116-28",
     "LID": "10.1016/j.neuron.2010.05.030 [doi]",
     "AB": "Although the extracellular matrix plays an important role in regulating use-dependent synaptic plasticity, the underlying molecular mechanisms are poorly understood. Here we examined the synaptic function of hyaluronic acid (HA), a major component of the extracellular matrix. Enzymatic removal of HA with hyaluronidase reduced nifedipine-sensitive whole-cell Ca(2+) currents, decreased Ca(2+) transients mediated by L-type voltage-dependent Ca(2+) channels (L-VDCCs) in postsynaptic dendritic shafts and spines, and abolished an L-VDCC-dependent component of long-term potentiation (LTP) at the CA3-CA1 synapses in the hippocampus. Adding exogenous HA, either by bath perfusion or via local delivery near recorded synapses, completely rescued this LTP component. In a heterologous expression system, exogenous HA rapidly increased currents mediated by Ca(v)1.2, but not Ca(v)1.3, subunit-containing L-VDCCs, whereas intrahippocampal injection of hyaluronidase impaired contextual fear conditioning. Our observations unveil a previously unrecognized mechanism by which the perisynaptic extracellular matrix influences use-dependent synaptic plasticity through regulation of dendritic Ca(2+) channels.",
     "FAU": [
          "Kochlamazashvili, Gaga",
          "Henneberger, Christian",
          "Bukalo, Olena",
          "Dvoretskova, Elena",
          "Senkov, Oleg",
          "Lievens, Patricia M-J",
          "Westenbroek, Ruth",
          "Engel, Andreas K",
          "Catterall, William A",
          "Rusakov, Dmitri A",
          "Schachner, Melitta",
          "Dityatev, Alexander"
     ],
     "AU": [
          "Kochlamazashvili G",
          "Henneberger C",
          "Bukalo O",
          "Dvoretskova E",
          "Senkov O",
          "Lievens PM",
          "Westenbroek R",
          "Engel AK",
          "Catterall WA",
          "Rusakov DA",
          "Schachner M",
          "Dityatev A"
     ],
     "AD": "Zentrum fur Molekulare Neurobiologie Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 85, Hamburg, Germany.",
     "LA": [
          "eng"
     ],
     "GR": [
          "G0900613/Medical Research Council/United Kingdom",
          "Medical Research Council/United Kingdom",
          "G0802216/Medical Research Council/United Kingdom",
          "G0802216(89644)/Medical Research Council/United Kingdom",
          "G0900613(91064)/Medical Research Council/United Kingdom",
          "084311/Wellcome Trust/United Kingdom",
          "Wellcome Trust/United Kingdom"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Neuron",
     "JT": "Neuron",
     "JID": "8809320",
     "RN": [
          "0 (Calcium Channel Agonists)",
          "0 (Calcium Channel Blockers)",
          "0 (Calcium Channels, L-Type)",
          "71145-03-4 (3-Pyridinecarboxylic acid,",
          "1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester)",
          "9004-61-9 (Hyaluronic Acid)",
          "EC 3.2.1.35 (Hyaluronoglucosaminidase)",
          "I9ZF7L6G2L (Nifedipine)"
     ],
     "SB": "IM",
     "MH": [
          "3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology",
          "Analysis of Variance",
          "Animals",
          "CHO Cells",
          "Calcium Channel Agonists/pharmacology",
          "Calcium Channel Blockers/pharmacology",
          "Calcium Channels, L-Type/genetics/*physiology",
          "Conditioning, Classical/drug effects",
          "Cricetinae",
          "Cricetulus",
          "Drug Interactions",
          "Electric Stimulation/methods",
          "Fear/drug effects",
          "Female",
          "Hippocampus/*cytology/physiology",
          "Hyaluronic Acid/*metabolism",
          "Hyaluronoglucosaminidase/pharmacology",
          "In Vitro Techniques",
          "Long-Term Potentiation/drug effects/*physiology",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Nifedipine/pharmacology",
          "Patch-Clamp Techniques/methods",
          "Synapses/*physiology",
          "Transfection/methods"
     ],
     "PMC": "PMC3378029",
     "MID": [
          "UKMS34712"
     ],
     "OID": [
          "NLM: UKMS34712"
     ],
     "EDAT": "2010/07/14 06:00",
     "MHDA": "2010/08/07 06:00",
     "CRDT": [
          "2010/07/14 06:00"
     ],
     "PHST": [
          "2010/05/24 00:00 [accepted]",
          "2010/07/14 06:00 [entrez]",
          "2010/07/14 06:00 [pubmed]",
          "2010/08/07 06:00 [medline]"
     ],
     "AID": [
          "S0896-6273(10)00426-5 [pii]",
          "10.1016/j.neuron.2010.05.030 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuron. 2010 Jul 15;67(1):116-28. doi: 10.1016/j.neuron.2010.05.030.",
     "term": "hippocampus"
}